Elsevier

Life Sciences

Volume 52, Issue 25, 1993, Pages 2005-2015
Life Sciences

Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder

https://doi.org/10.1016/0024-3205(93)90685-VGet rights and content

Abstract

Platelet serotonin (5-HT) studies were conducted with 12 hyperserotonemic and 12 normoserotonemic age-, sex-, and relationship-matched relatives of autistic probands. Each group consisted of 7 mothers, 4 fathers, and 1 sister of autistic children and adolescents. The density (Bmax) of platelet 5-HT2 receptor binding sites, labelled with [3H]-lysergic acid diethylamide (LSD), was significantly lower in 11 hyperserotonemic subjects compared to 12 normoserotonemic subjects (40.9 ± 13.5 fmol/mg protein, 59.6 ± 13.2; p < 0.004). The affinity (Kd) for [3H]-LSD binding did not differ. Although the density (Bmax) of [3H]-paroxetine binding did not differ between groups, there was a small difference in the affinity (Kd) of [3H]-paroxetene binding (hyperserotonemic 47.6 ± 9.0 pM, normoserotonemic 54.8 ± 12.1; p < 0.05). There were no significant differences in platelet 5-HT uptake, or in thrombin-stimulated 5-HT release. Basal, 5-HT-stimulated, and arginine-vasopressin (AVP)-stimulated inositol phosphate production, as well as basal, prostaglandin E1 (PGE1)-, and forskolin-stimulated cAMP production did not differ. There were significant correlations between whole blood 5-HT levels and LSD Bmax (rs = −0.63, N=23, p < 0.002) and whole blood 5-HT levels and 5-HT uptake Vmax (rs = 0.56, N=18, p < 0.02). However, [3H]-LSD labelled 5-HT2 binding and 5-HT uptake were not correlated with each other. Hyperserotonemia of autism may be heterogeneous with one subgroup of subjects with increased 5-HT uptake and another subgroup with decreased 5-HT2 binding.

References (36)

  • R.J. Schain et al.

    J. Pediatrics

    (1961)
  • E. Ritvo et al.

    Biochem. Med.

    (1971)
  • S. Kuperman et al.

    J. Am. Acad. Child Psychiatry

    (1985)
  • P. Simonsson et al.

    Life Sci.

    (1988)
  • G.M. Anderson et al.

    Biochim. Biophys. Acta

    (1992)
  • G.M. Anderson et al.

    Life Sci.

    (1987)
  • D.P. Geaney et al.

    Eur. J. Pharmacol.

    (1984)
  • R. Arora et al.

    Clin. Chim. Acta

    (1981)
  • N.L. Baenziger et al.

    Methods Enzymol.

    (1974)
  • O.H. Lowry et al.

    J. Biol. Chem.

    (1951)
  • G.M. Anderson et al.

    Anal. Biochem.

    (1992)
  • G.L. Brammer et al.

    Life Sci.

    (1987)
  • D. Chatterjee et al.

    Life Sci.

    (1990)
  • E.R. Ritvo et al.

    Arch. Gen. Psychiatry

    (1970)
  • G.M. Anderson et al.

    J. Child Psychol. Psychiat.

    (1987)
  • E. Geller et al.

    J. Autism Dev. Disord.

    (1988)
  • H.G. Hanley et al.

    Arch. Gen. Psychiatry

    (1977)
  • A. Yuwiler et al.

    Biochem. Med.

    (1970)
  • Cited by (155)

    • The serotonin system in autism spectrum disorder: From biomarker to animal models

      2016, Neuroscience
      Citation Excerpt :

      The potential mechanisms underlying platelet 5-HT levels have been explored both in ASD families and in the general population. Essentially, elevated 5-HT levels in platelets could be due to one of four mechanisms: increased 5-HT production by enterochromaffin cells in the intestine, increased uptake of 5-HT into the platelet, decreased metabolic breakdown of 5-HT, or altered platelet release (Cook et al., 1993a). Most studies have focused on the platelet, rather than on the source of 5-HT in the gut.

    • Serotonin mediated immunoregulation and neural functions: Complicity in the aetiology of autism spectrum disorders

      2015, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      A recent functional magnetic resonance imaging study by Daly et al. (2012) suggested significant differences in acute depletion of TRP modulated spatial-facial expressions of emotions by 5-HT between adult ASD and control subjects. Study with partial agonist of 5-HT2A receptor, 3H-lysergic acid diethylamide has revealed significant reduction in binding affinity of 5-HT2A receptor in first-degree relatives of hyperserotonemic as compared to that of normoserotonemic autistic children (Cook et al., 1993). Children with ASD are at higher risk to develop gastrointestinal (GI) problems (Ibrahim et al., 2009).

    View all citing articles on Scopus
    View full text